Granel B, Serratrice J, Dodé C, Grateau G, Disdier P, Weiller P-J
Service de Médecine Interne, Assistance Publique Hôpitaux de Marseille (AP-HM), Centre Hospitalier de la Timone, Marseille, France.
Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S93-5.
Familial Mediterranean Fever (FMF) and TNF-Receptor Associated Periodic Syndrome (TRAPS) are two inheritable inflammatory disorders. They share some clinical manifestations but their treatments are different. We present here the case of an overlap syndrome of FMF and TRAPS in a patient carrying a mutation in both the MEFV and TNFRSF1A genes.
A 20-year-old woman of Mediterranean origin had suffered since childhood from attacks of fever and arthritis, with skin and ophthalmic manifestations. The initial diagnosis was FMF. The symptoms responded poorly to colchicine but regressed with steroids. Genetic analysis revealed a homozygous M694V mutation in MEFV and a heterozygous R92Q mutation in TNFRSF1A. We discuss the complexity of this combined FMF-TRAPS phenotype.
This case shows that mutations in MEFV and TNFRSF1A can occur together in a single patient, a condition that may modify its response to treatment. It would be interesting to evaluate the role of the R92Q mutation in TNFRSF1A in patients of Mediterranean origin with FMF unresponsive to colchicine.
家族性地中海热(FMF)和肿瘤坏死因子受体相关周期性综合征(TRAPS)是两种遗传性炎症性疾病。它们有一些共同的临床表现,但治疗方法不同。我们在此报告一例携带MEFV和TNFRSF1A基因双突变患者的FMF与TRAPS重叠综合征病例。
一名20岁的地中海裔女性自幼患有发热和关节炎发作,并伴有皮肤和眼部表现。最初诊断为FMF。症状对秋水仙碱反应不佳,但使用类固醇后消退。基因分析显示MEFV基因存在纯合M694V突变,TNFRSF1A基因存在杂合R92Q突变。我们讨论了这种FMF-TRAPS联合表型的复杂性。
该病例表明MEFV和TNFRSF1A突变可在同一患者中同时出现,这种情况可能会改变其对治疗的反应。评估TNFRSF1A基因中R92Q突变在地中海裔FMF患者中对秋水仙碱无反应的作用可能会很有意思。